Meeting
2023 ASCO Annual Meeting
Long term efficacy of psilocybin in cancer patients with major depressive disorder (MDD).
Authors
Manish Agrawal
Sunstone Therapies, Rockville, MD
Manish Agrawal , Sarah Shnayder , Heather Honstein , Ezekiel J. Emanuel , Paul M. Thambi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Symptoms and Survivorship
Track
Symptom Science and Palliative Care
Sub Track
Palliative Care and Symptom Management
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 12021)
DOI
10.1200/JCO.2023.41.16_suppl.12021
Abstract #
12021
Poster Bd #
389
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
High-dose furmonertinib in patients with EGFR-mutated non-small cell lung cancer and leptomeningeal metastases: A real-world study.
First Author: Haiyang Chen
Poster
2024 ASCO Annual Meeting
Nutraceutical and dietary supplement use in the cancer population: The impact of evidence-based education.
First Author: Rubal Sharma
Poster
2024 ASCO Annual Meeting
Safety and efficacy of olutasidenib treatment in elderly patients with relapsed/refractory mIDH1 acute myeloid leukemia.
First Author: Stéphane De Botton
Poster
2024 ASCO Genitourinary Cancers Symposium
Enfortumab vedotin treatment regimens and efficacy in urothelial carcinoma: The Mayo Clinic experience.
First Author: Tara Ballouz